FDA Considering Independent Evaluation for DNA Contamination in COVID-19 Vaccines

The Food and Drug Administration is mulling over conducting its own evaluation of the levels of DNA in COVID-19 vaccines, an FDA official has disclosed.

“I’ll say that that is something that’s being discussed,” Dr. Tracy Hoeg, a senior adviser to the FDA’s commissioner, told members of the Centers for Disease Control and Prevention’s vaccine advisory panel on Sept. 19.

Before the panel’s members unanimously recommended during the meeting that the CDC roll back COVID-19 vaccine recommendations, a number expressed concerns about growing evidence of higher-than-allowed levels of DNA in the vaccines, the spreadofthevaccinebeyond the injection site, and the long-term persistence of messenger ribonucleic acid (mRNA)—a key part of the Pfizer-BioNTech and Moderna shots.

The CDC has described mRNA as the entity teaching cells how to make copies of the spike protein to enable protection when the real virus, with its own spike protein, attacks the body. “After the mRNA delivers the instructions, your cells break it down and get rid of it,” a CDC graphic states.

Retsef Levi, chair of the advisory panel’s COVID-19 immunization workgroup, showed the graphic during the meeting.

“We have a range of things on the mRNA platforms that really suggests that it doesn’t work as intended,” Levi said, citing issues such as the spread of spike protein and mRNA into various parts of the body and “DNA contamination.”

Keep reading

Vaccine panel avoids big changes to childhood immunizations, COVID shots

The panel that develops vaccine recommendations for the Centers for Disease Control and Prevention proposed one change to childhood immunizations but tabled a vote for another before turning their attention to the hotly debated COVID-19 vaccines.

The Advisory Committee on Immunization Practices continued its two-day meeting Friday after voting Thursday to recommend a standalone chickenpox vaccination in toddlers to reduce their risk of febrile seizures.

A combination MMRV vaccine is available, which includes measles, mumps, rubella and varicella (chickenpox) immunizations.

All of those vaccines are recommended for kids at 12 months and again between 4 and 6 years.

The panel recommended a separate MMR and chickenpox shot for children on the initial doses.

The panel on Friday decided to table a vote on delaying the first dose of the hepatitis B vaccine, which is currently recommended at birth.

Keep reading

CDC panel votes to push back MMRV vaccine recommendation to 4 years old

The vaccine advisory panel for the Centers for Disease Control and Prevention (CDC) voted Thursday in favor of delaying the administration of the vaccine for measles, mumps, rubella and varicella (chickenpox), commonly called the MMRV. 

The CDC’s Advisory Committee on Immunization Practices (ACIP) is scheduled to vote on three questions during Thursday’s meeting. Five of the members were appointed to the committee just this week. 

First, the panel was asked to consider whether the MMRV vaccine should not be recommended for children younger than 4. The panel voted 8-3 to approve the change, with one member abstaining.  

This vote would have meant that children who receive their vaccinations through the Vaccines For Children federal program will not be able to receive the MMRV shot until they’re 4 years old. The committee voted, however, in a follow-up motion against aligning the VFC with the recommendation, changing nothing in terms of what the program covers for the time being.

Children can normally get the MMRV vaccine beginning at 12 months of age.

ACIP members Hillary Blackburn, Cody Meissner and Joseph Hibbeln were the three members to vote no on the recommendation.

The panel decided to delay the votes on hepatitis B vaccine guidance until Friday, when they will also vote on COVID-19 vaccine guidance.

The meeting Thursday was tense, with panel members very aware of the heightened attention on their vote following the firing and resignation of top CDC officials and the growing scrutiny of Health and Human Services Secretary Robert F. Kennedy Jr. on Capitol Hill. 

“We are currently experiencing heated controversies about vaccines. And a key question is, who can you trust? Here’s my advice, when there are different scientific views, only trust scientists who are willing to engage with and publicly debate the scientists with other views,” ACIP Chair Martin Kulldorff said at the start of the meeting. 

Keep reading

RFK Jr’s hand-picked CDC advisory panel recommends against combo vaccine for kids 

Health Secretary Robert F. Kennedy Jr.’s overhauled vaccine panel voted on Thursday to no longer recommend a combination shot protecting against chickenpox, measles, mumps and rubella for young children. 

In an 8-3 vote, with one member abstaining, the Advisory Committee on Immunization Practices (ACIP) decided against recommending the MMRV vaccine for children under the age of 4. 

The panel, which advises the Centers for Disease Control and Prevention (CDC) on which vaccines to recommend to the American public, said children younger than 4 should instead be immunized for varicella (the virus that causes chickenpox) separately from a combined shot for measles, mumps and rubella (MMR). 

Concerns over the rare risk of fever-induced seizures related to MMRV vaccines were brought up by some members of the panel. 

Committee member Dr. Cody Meissner, who voted to continue recommending the MMRV vaccine for young children, described so-called “febrile seizures” as “a very frightening experience” for parents during the ACIP meeting. 

Keep reading

RFK Jr. vaccine advisers to examine shots during pregnancy

A panel of federal vaccine advisers appointed by Health and Human Services Secretary Robert F. Kennedy Jr. will launch a new review on the use of vaccines during pregnancy, the panel’s chair said.  

Martin Kulldorff, a statistician and former Harvard professor who chairs the Advisory Committee on Immunization Practices at the Centers for Disease Control and Prevention (CDC), made the announcement at the start of Thursday’s meeting, where panelists will consider recommendations related to the pediatric vaccine schedule, including hepatitis B. 

The panel is set to vote later Thursday on changing the current recommendation that infants receive the hepatitis B vaccine at birth. 

Another working group will examine the vaccines given between childhood and adolescence, Kulldorff said. 

Most of the working groups consider a singular vaccine or group of related vaccines, Kulldorff noted, not broad categories or the entire concept of a vaccine schedule. 

Thursday’s meeting comes after a tense Senate hearing Wednesday where former CDC Director Susan Monarez testified she was fired after refusing to rubber-stamp the panel’s recommendations before they were made. Kennedy handpicked the panelists, many of whom are critical about vaccinations, after firing their predecessors 

In his opening remarks, Kulldorff challenged nine former heads of the CDC to a public debate on vaccination, after they accused him and the panelists of being unqualified and of spreading “dangerous and unscientific views.”  

“False accusations that we and other respectable vaccine scientists are unscientific and dangerous anti-vaxxers, that just adds legitimacy to anti-vax positions, damaging both public health and the confidence in vaccines,” Kulldorff said.  

Kulldorff said if the former directors won’t have a debate, they shouldn’t be trusted. 

Keep reading

RFK Jr. Plans to Change Childhood Vaccine Schedule, Ousted CDC Director Says

Susan Monarez said during a Senate Health Committee hearing in Washington that Kennedy said during an Aug. 25 meeting that the childhood vaccine schedule would be changed in September.

“We got into an exchange where I had suggested I would be open to changing childhood vaccine schedules if the evidence or science were supportive, and he responded that there was no science or evidence associated with the childhood vaccine schedule,” Monarez said.

“Any potential changes to the childhood vaccine schedule will be based on the latest available science and only after the ACIP recommends it and the Acting CDC Director reviews and approves those recommendations,” a spokesperson for the Department of Health and Human Services, the CDC’s parent agency, told The Epoch Times in an email.

Monarez said, “The childhood vaccine schedule has been vetted and validated through science and evidence.”

Every vaccine on the schedule is important, she said.

Keep reading

Rand Paul Dismantles Ex-CDC Chief in Brutal Senate Showdown

Ex-CDC Director Dr. Susan Monarez testified today before the Senate HELP Committee in a desperate attempt to smear RFK Jr.’s name and build pressure for him to resign.

But things didn’t go according to plan. Senator Rand Paul wasn’t about to let that happen. After Monarez got a few softball questions from Bernie Sanders and others, Paul stepped in with the tough ones.

He started with the basics—asking if the COVID vaccines actually stop transmission.

PAUL: “Does the COVID vaccine prevent transmission?”

MONAREZ: “The COVID vaccine can reduce viral load in individuals who are—”

PAUL: “Does it prevent transmission?”

MONAREZ: “When you have reduced viral load… you will have reduced transmission.”

PAUL: “But in other words, it DOESN’T prevent transmission. You can still transmit the virus if you’ve had the vaccine.”

Keep reading

Fugitive Vaccine Researcher Behind Infamous ‘No Autism Link’ Study ARRESTED for Stealing $1 Million from CDC

Breitbart News has reported that Poul Thorsen, the Danish researcher whose work has been used for two decades to dismiss any link between vaccines and autism, has finally been arrested in Germany after more than a decade as a fugitive.

Thorsen, 64, was indicted by a federal grand jury in Atlanta in 2011 on 22 counts of wire fraud and money laundering. Prosecutors allege that from 2004 to 2010, he stole more than $1 million in CDC research funds—money intended to study autism, infant disabilities, genetic disorders, and fetal alcohol syndrome. According to the indictment, Thorsen funneled funds into his own accounts using fraudulent invoices on CDC letterhead.

He has been on the HHS “Most Wanted” list for over a decade. Acting on an INTERPOL red notice, German authorities finally took him into custody in June. The Department of Justice is now working with Germany to extradite him for trial in the United States.

Keep reading

‘PFIZERGATE’: EU Commission Forced To Admit That COVID ‘Vaccines’ Were Given to the Population Without ‘Complete Safety Data’

The COVID jabs were ineffective, untested and unsafe.

Whatever else happens in the career of the European Commissioner Ursula von der Leyen, her legacy will always be tainted by the Pfizergate scandal.

It’s true that she did survive a motion of censure (or vote of no-confidence) that was brought by Romanian nationalist Gheorghe Piperea.

The author of the motion criticized the Commission’s refusal to disclose text messages between von der Leyen and the chief executive of vaccine maker Pfizer during the COVID-19 crisis.

But while the lack of transparency and suspicion of corruption are bad enough, there’s an even darker side to this story: as we all know, the mRNA shots were untested and unsafe.

Keep reading

Moderna’s COVID Shot Plasmid Contains Human Blood Gene Fragment Capable of Integrating Into DNA—Same System Dominating Post-Vaccine Injuries

Moderna’s COVID-19 vaccine plasmid contains a human α-globin DNA fragment regulating blood and cardiovascular biology, and because plasmids are integration-competent DNA molecules, this fragment is capable of inserting into the human genome—precisely as blood and cardiovascular injuries like myocarditis and pericarditis emerge as the dominant serious adverse events following Moderna vaccination.

In plain terms, Moderna’s shot carries a piece of human blood gene code that can lodge itself into patient DNA, raising the possibility that the very blueprint of the vaccine is fueling the same heart and blood injuries now seen at the top of its safety reports.

While most public discussion blames the spike protein or lipid nanoparticles for Moderna’s adverse events, the evidence here points to something no one is talking about—the plasmid blueprint itself may be driving the blood and heart injuries dominating the safety signal.

A September 2025 peer-reviewed paper in Molecular Therapy: Nucleic Acids confirms that Moderna’s mRNA-1273 (Spikevax) vaccine plasmid carries a 3’ untranslated region (UTR) from the human α-globin (HBA1) gene.

  • α-globin encodes part of hemoglobin, central to red blood cell stability and oxygen transport.
  • Its regulation is directly tied to blood and cardiovascular function—mutations cause α-thalassemia, anemia, and cardiac stress.
  • By design, Moderna’s blueprint hard-codes this human blood gene regulator into the plasmid template.

Keep reading